Company Information

SOLARA ACTIVE PHARMA SCIENCES LTD.

NSE : SOLARABSE : 541540ISIN CODE : INE624Z01016Industry : Pharmaceuticals & DrugsHouse : Private
BSE375.50-6.7 (-1.75 %)
PREV CLOSE ( ) 382.20
OPEN PRICE ( ) 385.95
BID PRICE (QTY) 375.05 (25)
OFFER PRICE (QTY) 375.50 (450)
VOLUME 9299
TODAY'S LOW / HIGH ( )374.00 389.10
52 WK LOW / HIGH ( )287 507.2
NSE375.60-7.8 (-2.03 %)
PREV CLOSE( ) 383.40
OPEN PRICE ( ) 382.00
BID PRICE (QTY) 375.60 (32)
OFFER PRICE (QTY) 375.65 (15)
VOLUME 110499
TODAY'S LOW / HIGH( ) 374.00 392.00
52 WK LOW / HIGH ( )286 506.5
Managing DirectorPoorvank Purohit
Company SecretaryS Murali Krishna
Non Executive DirectorArun Kumar
Kartheek Chintalapati Raju
Ankur Nand Thadani
Non Executive Independent DirectorKausalya Santhanam
R Ramakrishnan
Rajendra Kumar Srivastava
Rajiv Vijay Nabar
Incorporation Year : 23-02 2017

Registered Office :

Address : 201, Devavrata,Sector 17,Vashi Navi Mumbai,
Maharashtra-400703 .

Phone : 022 2789 2924 / 2789 3199

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.